Refreshing results…
Venetoclax–based low intensity therapy in molecular failure of NPM1-mutated AML
Download from doi.orgTP53mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype
Download from ashpublications.orgAcquired mutations in BAX confer resistance to BH3-mimetic therapy in Acute Myeloid Leukemia
Download from ashpublications.orgDescription of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertions
Download from ashpublications.orgOutcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms
UploadMissing publications? Search for publications with a matching author name.